$3.75
0.61[19.43%]
At close: Apr 26
$3.75
0[0.00%]
After Hours: 7:49PM EDT
NRX Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of NRX Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/14/2024 | AM | NRXP | Q1 | -$1.60 | -$0.50 | — | — | $0.00 | — | — | — | Get Alert |
03/28/2024 | PM | NRXP | Q4 | -$1.60 | -$0.70 | -$0.50 | 28.57% | $0.00 | — | $0.00 | — | Get Alert |
11/13/2023 | PM | NRXP | Q3 | -$1.40 | -$1.20 | -$0.70 | 41.67% | $0.00 | — | $0.00 | — | Get Alert |
08/14/2023 | PM | NRXP | Q2 | -$1.10 | -$1.40 | -$1.20 | 14.29% | $0.00 | — | $0.00 | — | Get Alert |
05/16/2023 | AM | NRXP | Q1 | -$2.10 | -$1.40 | -$1.60 | -14.29% | $0.00 | — | $0.00 | — | Get Alert |
03/30/2023 | PM | NRXP | Q4 | -$0.90 | -$1.40 | -$1.60 | -14.29% | $0.00 | — | $0.00 | — | Get Alert |
11/14/2022 | AM | NRXP | Q3 | -$4.00 | -$1.40 | -$1.40 | 0.00% | $0.00 | — | $0.00 | — | Get Alert |
08/15/2022 | AM | NRXP | Q2 | -$3.80 | — | -$1.10 | — | $0.00 | — | $0.00 | — | Get Alert |
05/16/2022 | AM | NRXP | Q1 | -$7.10 | — | -$2.10 | — | $0.00 | — | $0.00 | — | Get Alert |
03/31/2022 | AM | NRXP | Q4 | — | — | -$0.90 | — | — | — | $0.00 | — | Get Alert |
11/16/2021 | AM | NRXP | Q3 | -$1.50 | — | -$4.00 | — | $0.00 | — | $0.00 | — | Get Alert |
08/16/2021 | PM | NRXP | Q2 | — | — | -$3.80 | — | — | — | $0.00 | — | Get Alert |
NRX Pharmaceuticals (NRXP) is scheduled to report earnings on May 14, 2024. The last reported earnings were for reported on March 28, 2024 for Q4.
The Actual EPS was $-0.50, which beat the estimate of $-0.70.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.